132294-14-5 Usage
Physical state
Colorless liquid
Configuration
trans
Ethoxy group positioning
Opposite sides of the cyclobutane ring
Applications
Building block in the synthesis of pharmaceuticals and fine chemicals
Industry relevance
Pharmaceutical industry, specialty chemicals, and materials production
Safety concerns
Potential toxicity and flammability, requiring careful handling
Check Digit Verification of cas no
The CAS Registry Mumber 132294-14-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,2,9 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 132294-14:
(8*1)+(7*3)+(6*2)+(5*2)+(4*9)+(3*4)+(2*1)+(1*4)=105
105 % 10 = 5
So 132294-14-5 is a valid CAS Registry Number.
132294-14-5Relevant articles and documents
CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS
-
Paragraph 0250; 0286, (2020/07/07)
Described herein are cyclobutyl nucleoside analogs of Formula (I), pharmaceutical compositions that include one or more cyclobutyl nucleoside analogs and methods of using the same to treat HBV, HDV and/or HIV.
Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues
Bisacchi,Braitman,Cianci,Clark,Field,Hagen,Hockstein,Malley,Mitt,Slusarchyk,Sundeen,Terry,Tuomari,Weaver,Young,Zahler
, p. 1415 - 1421 (2007/10/02)
The syntheses of the enantiomeric cyclobutyl guanine nucleoside analogues [1R-1α,2β,3α]- and [1S-1α,2β,3α]-2-amino-9-[2,3-bis(hydroxymethyl) cyclobutyl]-6H-purin-6-one (7 and 8, respectively) and the enantiomeric cyclobutyl adenine analogues [1R-1α,2β,3α]
